UnitedHealth Group · Multi-Quarter Financial Trends

16 quarters · As reported by the company · Amounts in USD billions← UNH

Quarter	Period End	Revenue ($B)	YoY	Gross Margin	Operating Income ($B)	Net Income ($B)	Net Margin	Free Cash Flow ($B)	EPS	Buybacks ($B)	Dividends ($B)
FY2026 Q2	2026-06-30	112.03	+0.4%	88.1%	7.99	5.48	4.9%	10.25	6.04	1.65	2.09
FY2026 Q1	2026-03-31	111.72	+2.0%	88.5%	8.99	6.28	5.6%	8.15	6.90	0.00	2.01
FY2025 Q4	2025-12-31	113.22	+12.3%	88.8%	0.38	0.01	0.0%	0.16	0.05	0.00	2.00
FY2025 Q3	2025-09-30	113.16	+12.2%	88.9%	4.32	2.35	2.1%	5.06	2.59	0.00	2.00
FY2025 Q2	2025-06-30	111.62	+12.9%	88.3%	5.15	3.41	3.1%	6.30	3.74	2.55	2.00
FY2025 Q1	2025-03-31	109.58	+9.8%	88.7%	9.12	6.29	5.7%	4.56	6.85	3.00	1.91
FY2024 Q4	2024-12-31	100.81	+6.8%	87.6%	7.77	5.54	5.5%	1.46	5.99	4.97	1.93
FY2024 Q3	2024-09-30	100.82	+9.2%	88.3%	8.71	6.06	6.0%	12.95	6.51	0.96	1.94
FY2024 Q2	2024-06-30	98.86	+6.4%	88.5%	7.88	4.22	4.3%	5.89	4.54	0.00	1.94
FY2024 Q1	2024-03-31	99.80	+8.6%	88.9%	7.93	-1.41	-1.4%	0.40	-1.53	3.07	1.73
FY2023 Q4	2023-12-31	94.43	+14.1%	89.2%	7.69	5.46	5.8%	-6.15	5.85	1.50	1.74
FY2023 Q3	2023-09-30	92.36	+14.2%	89.8%	8.53	5.84	6.3%	6.06	6.24	1.50	1.74
FY2023 Q2	2023-06-30	92.90	—	89.5%	8.06	5.47	5.9%	10.20	5.82	3.00	1.75
FY2023 Q1	2023-03-31	91.93	—	89.8%	8.09	5.61	6.1%	15.57	5.95	2.00	1.54
FY2022 Q4	2022-12-31	82.79	—	90.0%	6.89	4.76	5.8%	-5.40	5.02	1.00	1.54
FY2022 Q3	2022-09-30	80.89	—	89.7%	7.46	5.26	6.5%	17.83	5.55	1.00	1.54

Quarterly figures come from the company's 10-Q and 10-K filings. The fourth quarter is derived as the full year minus the first three quarters; cash flow items are converted from fiscal year-to-date totals into single quarters.